Gilbert, SM
Oliphant, CJ
Hassan, S.
Peille, AL
Bronsert, P. http://orcid.org/0000-0001-8558-0347
Falzoni, S.
Di Virgilio, F.
McNulty, S.
Lara, R.
Funding for this research was provided by:
Innovate UK (710832, 710832, 710832, 710832)
Article History
Received: 15 November 2017
Revised: 13 July 2018
Accepted: 14 July 2018
First Online: 7 August 2018
Compliance with ethical standards
:
: SMG, CJO, SM and RL are employees of Biosceptre (UK) Limited, a company commercialising nfP2X7-targeted therapies. ALP and PB were contracted by Biosceptre (UK) Limited as part of Charles River Discovery Research Services Germany GmbH (formerly named Oncotest GmbH). SH is BBSRC CASE PhD student partly funded by Biosceptre (UK) Limited. FDV serves as a member of Biosceptre International Limited’s Scientific Advisory Board. SF has no conflict of interest.